An interaction with the furniture: Fatal forty DDI: Warfarin, metronidazole, ciprofl oxacin, CYP2C9, CYP1A2

Heather Norvelle; Ines P. Koerner

doi:10.1007/978-1-4614-7495-1_147

An interaction with the furniture: Fatal forty DDI: Warfarin, metronidazole, ciprofl oxacin, CYP2C9, CYP1A2

Heather Norvelle, Ines P. Koerner

Anesthesiology and Perioperative Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

This case discusses a possible and/or likely pharmacokinetic interaction involving warfarin, metronidazole, and ciprofl oxacin, leading to bleeding complications. Warfarin is a cytochrome P450 2C9 and 1A2 substrate. Metronidazole is a 2C9 inhibitor and ciprofl oxacin is a 1A2 inhibitor.

Original language	English (US)
Title of host publication	A Case Approach to Perioperative Drug-Drug Interactions
Publisher	Springer New York
Pages	661-664
Number of pages	4
ISBN (Electronic)	9781461474951
ISBN (Print)	9781461474944
DOIs	https://doi.org/10.1007/978-1-4614-7495-1_147
State	Published - Sep 15 2015

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-1-4614-7495-1_147

Cite this

@inbook{0c2926d9f5f0409f9907c2d6613ce1ab,

title = "An interaction with the furniture: Fatal forty DDI: Warfarin, metronidazole, ciprofl oxacin, CYP2C9, CYP1A2",

abstract = "This case discusses a possible and/or likely pharmacokinetic interaction involving warfarin, metronidazole, and ciprofl oxacin, leading to bleeding complications. Warfarin is a cytochrome P450 2C9 and 1A2 substrate. Metronidazole is a 2C9 inhibitor and ciprofl oxacin is a 1A2 inhibitor.",

author = "Heather Norvelle and Koerner, {Ines P.}",

year = "2015",

month = sep,

day = "15",

doi = "10.1007/978-1-4614-7495-1_147",

language = "English (US)",

isbn = "9781461474944",

pages = "661--664",

booktitle = "A Case Approach to Perioperative Drug-Drug Interactions",

publisher = "Springer New York",

}

TY - CHAP

T1 - An interaction with the furniture

T2 - Fatal forty DDI: Warfarin, metronidazole, ciprofl oxacin, CYP2C9, CYP1A2

AU - Norvelle, Heather

AU - Koerner, Ines P.

PY - 2015/9/15

Y1 - 2015/9/15

N2 - This case discusses a possible and/or likely pharmacokinetic interaction involving warfarin, metronidazole, and ciprofl oxacin, leading to bleeding complications. Warfarin is a cytochrome P450 2C9 and 1A2 substrate. Metronidazole is a 2C9 inhibitor and ciprofl oxacin is a 1A2 inhibitor.

AB - This case discusses a possible and/or likely pharmacokinetic interaction involving warfarin, metronidazole, and ciprofl oxacin, leading to bleeding complications. Warfarin is a cytochrome P450 2C9 and 1A2 substrate. Metronidazole is a 2C9 inhibitor and ciprofl oxacin is a 1A2 inhibitor.

UR - http://www.scopus.com/inward/record.url?scp=84955422181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955422181&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-7495-1_147

DO - 10.1007/978-1-4614-7495-1_147

M3 - Chapter

AN - SCOPUS:84955422181

SN - 9781461474944

SP - 661

EP - 664

BT - A Case Approach to Perioperative Drug-Drug Interactions

PB - Springer New York

ER -

An interaction with the furniture: Fatal forty DDI: Warfarin, metronidazole, ciprofl oxacin, CYP2C9, CYP1A2

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this